Company* |
Company |
Type/Product Area |
Terms/Details (Date) |
| |||
Affymetrix |
Teranode Corp. |
Program to support laboratory equipment integration |
Teranode is using the Affymetrix Develop- ment Kit in the deal; terms were not disclosed (11/22) |
DiscoveRx |
B-Bridge International |
Partnership to provide Japanese researchers better access to DiscoveRx screening assays |
They will collaborate to establish a local presence in Tokyo for DiscoveRx HitHunter products; terms were not disclosed (12/14) |
Diversa Corp. |
Givaudan Flavors Corp. |
Givaudan licensed the Accentuase-G enzyme for production of a natural flavor ingredient |
Under terms of the deal that began in 2002, Diversa gets a license fee and royalties from sales or use of the ingredient; Diversa also will manufacture the enzyme (11/22) |
DNA 2.0 Inc.* |
MediBIC (Japan) |
Collaboration on protein engineering and distribution of gene synthesis in Japan |
The consulting company also will be the sole Japanese distributor of DNA 2.0's existing repository of synthesized genes (12/13) |
Integrated |
Chr. Hansen (Denmark) |
Chr. Hansen licensed rights to IGI's ERGO database and genomic discovery system |
The natural ingredients company will use the system to study probiotics, for developing nutritional food ingredients (12/2) |
NuGEN |
MediBIC Inc.* (Japan) |
MediBIC will support the adoption of NuGEN's Ovation family of RNA amplification systems in Asia |
Terms of the deal were not disclosed (2/1) |
Phenomenome |
PrecisionMed Inc. |
Collaboration to develop diagnostics for Alzheimer's disease and bipolar disorder |
The effort will combine PrecisionMed's clinical samples and information and PDI's discovery and testing platform (2/4) |
| |||
Notes: | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. |